O'Shea, Aileen (2024) Coagulopathy and cannabinoids: what the radiologist should know. European Radiology, 34, (7), pp. 4538-4539. https://doi.org/10.1007/s00330-023-10532-3.
Commentary.
Synthetic cannabinoid–associated coagulopathy was initially described in IL, USA, in June 2018, when physicians and public health officials documented an association between these substances and over 150 patients who presented with bleeding diathesis and coagulopathy. It emerged that the cannabinoids had been contaminated with long-acting anticoagulant rodenticide, essentially super-warfarins...
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
E Concepts in biomedical areas > Pharmacology and toxicology > Purity / adulterant
G Health and disease > Cardiovascular / heart disease
VA Geographic area > Europe > Ireland
Click here to request a copy of this literature
Repository Staff Only: item control page